References
- KM Nicholson, and NG Anderson. (2002). Cell Signalling 14:381–395.
- JR Graff. (2002). Expert Opin Ther Targets 6:103–113.
- Q Li, and GD Zhu. (2002). Curr Top Med Chem 2:939–971.
- T Machajewski, L Xiaodong, AB Jefferson, and G Zhenai. (2005). Annu Rep Med Chem 40:263–276.
- SF Barnett, MT Bilodeau, and CW Lindsley. (2005). Curr Top Med Chem 5:109–125.
- WD Shipe, SE Wolkenberg, and CW Lindsley. (2005). Drug Discovery Today 2:155–161.
- SF Barnett, D Defeo-Jones, S Fu, PJ Hancock, KM Haskell, RE Jones, JA Kahana, AM Kral, K Leander, LL Lee, J Malinowski, EM McAvoy, DD Nahas, RR Robinson, and HE Huber. (2005). Biochem J 385:399–408.
- CW Lindsley, Z Zhao, WH Leister, RG Robinson, SF Barnett, D Defeo-Jones, RE Jones, GD Hartman, JR Huff, HE Huber, and ME Duggan. (2005). Bioorg Med Chem Lett 15:761–764.
- Z Zhao, WH Leister, RG Robinson, SF Barnett, D Defeo-Jones, RE Jones, GD Hartman, JR Huff, HE Huber, ME Duggan, and CW Lindsley. (2005). Bioorg Med Chem Lett 15:905–909.
- CC Kumar, and V Madison. (2005). Oncogene 24:7493–7501.
- J Guillon, I Forfar, M Mamani-Matsuda, V Desplat, M Saliège, D Thiolat, S Massip, A Tabourier, J-M Léger, B Dufaure, G Haumont, C Jarry, and D Mossalayi. (2007). Bioorg Med Chem 15:194–210.
- J Guillon, P Grellier, M Labaied, P Sonnet, J-M Léger, R Déprez-Poulain, I Forfar-Bares, P Dallemagne, N Lemaître, F Péhourcq, J Rochette, C Sergheraert, and C Jarry. (2004). J Med Chem 47:1997–2009.
- C Vidaillac, J Guillon, C Arpin, I Forfar-Bares, J Grellet, S Moreau, DH Caignard, C Jarry, and C Quentin-Noury. (2007). Antimicrob Agents Chemother 51:831–838.
- J Guillon, I Forfar, V Desplat, S Belisle Fabre, D Thiolat, S Massip, H Carrie, Mossalayi, and C Jarry. (2007). J Enz Inhib Med Chem 22:541–549.
- G Campiani, E Morelli, S Gemma, V Nacci, S Butini, M Hamon, E Novellino, G Greco, A Cagnotto, M Goegan, L Cervo, F Dalla Valle, C Fracasso, S Caccia, and T Mennini. (1999). J Med Chem 42:4362–4379.
- N Miyaura, and A Suzuki. (1995). Chem Rev 95:2457–2483.
- NM Ali, A McKillop, MB Mitchell, RA Rebelo, and PJ Wallbank. (1992). Tetrahedron 48:8117–8126.
- GA Molander, and T Fumagalli. (2006). J Org Chem 71:5743–5747.
- GA Molander, CS Yun, M Ribagorda, and B Biolatto. (2003). J Org Chem 68:5534–5539.
- J Guillon, M Boulouard, V Lisowski, S Stiebing, V Lelong, P Dallemagne, and S Rault. (2000). J Pharm Pharmacol 52:1369–1375.
- MB Young, JC Barrow, KL Glass, GF Lundell, CL Newton, JM Pellicore, KE Rittle, HG Selnick, KJ Stauffer, JP Vacca, PD Williams, D Bohn, FC Clayton, JJ Cook, JA Krueger, LC Kuo, SD Lewis, BJ Lucas, DR McMasters, C Miller-Stein, BL Pietrak, AA Wallace, RB White, B Wong, Y Yan, and PG Nantermet. (2004). J Med Chem 47:2995–3008.
- J Guillon, P Dallemagne, B Pfeiffer, P Renard, D Manechez, A Kervran, and S Rault. (1998). Eur J Med Chem 33:293–308.
- I Castellote, JJ Vaquero, J Fernandez-Gadea, and J Alvarez-Builla. (2004). J Org Chem 69:8668–8675.
- I Castellote, JJ Vaquero, and J Alvarez-Builla. (2004). Tetrahedron Lett 45:769–772.
- JR Berschied, and KF Purcell. (1970). Inorg Chem 19:624–629.
- CF Lane. (1975). Synthesis 2:135–146.
- Supplementary X-ray crystallographic data of compounds 1i and 1j (CCDC-662249 and CCDC-662250): Cambridge Crystallographic Data Centre, University Chemical Lab, 12 Union Road, Cambridge, CB2 1EZ, U.K.; [email protected].